Back to search
FDAFDA · Food and drugs·Recall number Z-0452-2014

Titanium Trochanteric Fixation Nail (TFN)System Intended to treat stable and unstable fractures of the proximal femur.

Published December 11, 2013 · Recall initiated: July 30, 2013

Summary

FDA records medical device Class II recall Z-0452-2014, published December 11, 2013 and initiated July 30, 2013. Recalling firm: Synthes USA HQ, Inc.; Status: Terminated; Reported quantity: 17; Lot: Part # 456.391S with lot numbers 5536930, exp. 5/20/2016, and 7161401, exp. 12/31/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Two lots of Titanium Trochanteric Fixation Nail (TFN) System are missing the second bend in the nail.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Synthes USA HQ, Inc.
Distributor
Nationwide Distribution including IL, CA, AZ, FL, TX, UT, VA, NY, NM, and MT.
Lot
Part # 456.391S with lot numbers 5536930, exp. 5/20/2016, and 7161401, exp. 12/31/2021.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Titanium Trochanteric Fixation Nail (TFN)System Intended to treat stable and unstable fractures of the proximal femur. recalled?

Yes. FDA published recall Z-0452-2014 on December 11, 2013. Reported hazard: Two lots of Titanium Trochanteric Fixation Nail (TFN) System are missing the second bend in the nail.

What should I do if I have this product?

Voluntary: Firm initiated · Letter